Open access · CC-BY
via OpenAlex
Proteomic Signature of Frailty Pace Reflects Biological Aging and Predicts Disease and Mortality
Jiachen Chen, Sandhya Iyer, Margaret F. Doyle, Joanne M. Murabito, Kathryn L. Lunetta
Innovation in Aging · 2025
Abstract
Abstract Frailty is a clinical manifestation of aging characterized by reduced physiological resilience and increased vulnerability to adverse outcomes. Plasma proteomics offers potential for tracking biological aging, yet few studies have used it to quantify frailty progression over time. We developed a proteomic signature representing the pace of frailty, derived from longitudinal trajectories of weight, grip strength, and gait speed in the Framingham Heart Study (FHS) Offspring cohort (N = 2,078, mean age 67 (SD = 9), 55% female). Using elastic net regression on 2,799 plasma proteins measured by the OLINK platform, we constructed a 112-protein signature spanning pathways related to muscle contraction, extracellular matrix interactions, homeostasis, immune responses and inflammation, metabolism, and neuronal system development. We validated the signature in two independent cohorts with plasma proteins measured by OLINK: the FHS Generation 3 (N = 3,130, mean age 46 (SD = 9), 53% female) and UK Biobank (N = 44,949, mean age 57 (SD = 8), 54% female). The signature was informative across adulthood and significantly associated (FDR ≤ 0.05) with the incidence of 19 major chronic diseases, including cardiometabolic, renal, pulmonary, hepatic, anemia, neurodegenerative, cerebrovascular, musculoskeletal, and oncologic conditions, as well as with all-cause mortality and age-related phenotypes such as telomere(definition) length, frailty index, blood pressure, lung function, reaction time and fluid intelligence score in UK Biobank, independent of age and other relevant covariates. Our findings demonstrate that the proteomic pace of frailty captures multiple biological processes underlying physiological decline and may serve as a prognostic biomarker of biological aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/geroni/igaf122.3833
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Chen, J., Iyer, S., Doyle, M.F., Murabito, J.M., & Lunetta, K.L. (2025). Proteomic Signature of Frailty Pace Reflects Biological Aging and Predicts Disease and Mortality. <em>Innovation in Aging</em>. https://doi.org/10.1093/geroni/igaf122.3833
Vancouver
Chen J, Iyer S, Doyle MF, Murabito JM, Lunetta KL. Proteomic Signature of Frailty Pace Reflects Biological Aging and Predicts Disease and Mortality. Innovation in Aging. 2025. doi:10.1093/geroni/igaf122.3833.
BibTeX
@article{jiachen2025Proteo,
title = {Proteomic Signature of Frailty Pace Reflects Biological Aging and Predicts Disease and Mortality},
author = {Jiachen Chen and Sandhya Iyer and Margaret F. Doyle and Joanne M. Murabito and Kathryn L. Lunetta},
journal = {Innovation in Aging},
year = {2025},
doi = {10.1093/geroni/igaf122.3833},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Medicine 2024
Open access · CC-BY
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations
Aging Cell 2026
Open access · CC-BY
Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease
Genes & Diseases 2025
Open access · CC-BY
Obesity accelerates aging: Mechanisms and therapeutic implications
Genes & diseases 2026
Open access · OA
Obesity accelerates aging: Mechanisms and therapeutic implications.
Aging Cell 2026
Open access · CC-BY
Plasma Proteome Profiling of Centenarian Across Switzerland Reveals Key Youth‐Associated Proteins
Aging cell 2026
Open access · OA